Importing transdermal patches into the US requires FDA registration, including device classification, 510(k) clearance, establishment registration, and QSR compliance. This step-by-step guide covers the entire process to help manufacturers navigate regulations and avoid costly delays.
The global transdermal patch market is projected to reach $12.5 billion by 2030, driven by chronic disease prevalence and technological innovations like microneedle and smart patches. Key trends include wearable integration and sustainable materials, with Asia-Pacific emerging as the fastest-growing region. Kongdy Health offers OEM solutions with FDA/ISO 13485/GMP certifications.
Brands are switching to transdermal patches over oral supplements due to superior bioavailability, improved compliance, and market demand. The patch delivery system bypasses the digestive tract, offering up to 90% bioavailability for certain ingredients. Learn how the supplement patch trend is reshaping the industry and how Kongdy Health can help you launch a successful patch product.
Market Size and Trajectory The global transdermal drug delivery systems market has experienced a compound annual growth rate (CAGR) of approximately 5.8% over the past five years, with valuations surpassing the USD 7.5 billion threshold in 2024. Industry projections indicate that this figure will approach USD 12 billion by 2032, driven by technological advancements in Read Full Article →
Navigating FDA Compliance for Transdermal Patch Importers The U.S. transdermal drug delivery market continues to expand, driven by patient preference for non-invasive therapies and the need for consistent drug absorption. For importers looking to bring transdermal patches into the United States, understanding the Food and Drug Administration (FDA) regulatory framework is not optional—it is a Read Full Article →